Medical Device 中的 India 事件

ABILITIES INDIA EXPO: India's Premier Exhibition for Accessibility and Inclusive Innovation

ABILITIES INDIA EXPO is India's premier exhibition dedicated to empowering persons with disabilities by showcasing the latest advancements in assistive technology, healthcare equipment, mobility solutions, educational services, accessible living products, and wellness innovations. Hosted at the KTPO Exhibition and Convention Centre in Bangalore, the event serves as a comprehensive platform where innovation, accessibility, and inclusion come together. Bringing manufacturers, healthcare providers, educators, NGOs, government organizations, distributors, and industry professionals under one roof, the expo creates meaningful opportunities for collaboration while promoting products and services that improve independence and quality of life.

With more than 1,000 exhibitors from across India, the exhibition highlights the country's growing commitment to accessible living and inclusive development. Visitors can explore a wide variety of solutions designed to support individuals with different physical, sensory, cognitive, and developmental needs. Beyond showcasing products, the event encourages dialogue between businesses, professionals, and end users, helping organizations better understand evolving accessibility requirements and develop solutions that make everyday life more inclusive.

A Comprehensive Platform for Accessibility and Innovation

As awareness of accessibility continues to grow, the demand for advanced assistive technologies and inclusive products is increasing across healthcare, education, employment, and public infrastructure. ABILITIES INDIA EXPO responds to this demand by providing a specialized environment where organizations can present innovative solutions while engaging directly with the people who benefit from them.

The exhibition covers a broad range of sectors, making it valuable for both business professionals and individuals seeking practical support. Manufacturers introduce cutting-edge mobility equipment, rehabilitation devices, communication technologies, accessible home products, and adaptive educational tools. Healthcare providers demonstrate therapeutic innovations, while technology companies present digital solutions that improve independence and everyday functionality.

Rather than functioning solely as a product showcase, the expo creates opportunities for meaningful conversations between developers, caregivers, medical professionals, educators, policymakers, and individuals living with disabilities. These interactions contribute to the continuous improvement of products and services by incorporating real-world experiences and user feedback into future innovation.

Products and Services Featured at the Expo

One of the greatest strengths of ABILITIES INDIA EXPO is the diversity of solutions presented throughout the exhibition. Visitors can compare products from numerous exhibitors while learning about emerging technologies that support mobility, communication, education, rehabilitation, and independent living.

The event showcases products suitable for children, adults, senior citizens, caregivers, rehabilitation centers, hospitals, educational institutions, and public organizations. From advanced mobility devices to smart accessibility technologies, exhibitors demonstrate practical solutions that help improve participation in education, employment, healthcare, and community life.

Visitors can expect to explore:

Assistive technology for communication, learning, and daily living.
Mobility aids including wheelchairs, walkers, scooters, and transfer equipment.
Healthcare and rehabilitation devices supporting physical recovery and therapy.
Accessible home products designed for greater comfort, safety, and independence.
Educational services, adaptive learning tools, and inclusive teaching resources.
Wellness products that promote healthier and more active lifestyles.

Interactive demonstrations allow attendees to experience many products firsthand, making it easier to evaluate their functionality, comfort, and suitability for individual needs. This practical approach helps families, caregivers, and organizations make informed decisions when selecting accessibility solutions.

Bringing Together Industry Leaders and Community Stakeholders

A defining feature of ABILITIES INDIA EXPO is its ability to connect every part of the accessibility ecosystem within a single venue. The exhibition welcomes manufacturers, distributors, rehabilitation specialists, hospitals, therapists, educational institutions, nonprofit organizations, government agencies, accessibility consultants, and technology developers.

For businesses, the event offers direct access to decision-makers responsible for procurement, distribution, and service delivery. Manufacturers can introduce new products, expand their market presence, and establish partnerships with organizations working in healthcare, education, rehabilitation, and public services. At the same time, healthcare professionals and service providers gain valuable insights into the latest innovations available for improving patient care and rehabilitation outcomes.

The exhibition also encourages collaboration between public and private sectors to advance inclusive policies and accessible infrastructure. Through networking opportunities and professional discussions, participants can exchange ideas, identify emerging challenges, and develop practical strategies for expanding accessibility across different industries.

Many professionals attend the expo with specific objectives:

Discover innovative assistive technologies and accessibility products.
Build partnerships with manufacturers, distributors, and service providers.
Learn about new developments in rehabilitation, healthcare, and inclusive education.
Expand business opportunities within the accessibility and wellness sectors.
Connect directly with users to better understand their needs and expectations.

These objectives make the exhibition valuable not only for commercial growth but also for encouraging long-term improvements in accessibility and social inclusion.

Advancing Inclusion Through Knowledge and Collaboration

Innovation in accessibility extends beyond technology alone. Effective inclusion requires collaboration among businesses, healthcare professionals, educators, policymakers, nonprofit organizations, and the communities they serve. ABILITIES INDIA EXPO supports this collaborative approach by creating an environment where expertise can be shared and new ideas can emerge.

Throughout the event, participants exchange knowledge about rehabilitation techniques, accessible design, inclusive education, digital accessibility, workplace accommodations, and community support services. These discussions help organizations remain informed about evolving standards, user expectations, and technological advancements while encouraging practical solutions that improve everyday experiences for people with disabilities.

The exhibition also provides opportunities for organizations to demonstrate their commitment to corporate social responsibility, inclusive employment, and accessible product development. By engaging directly with users and professionals, exhibitors gain valuable insights that contribute to more effective product design and service delivery.

Why ABILITIES INDIA EXPO Is a Landmark Event

As accessibility becomes an increasingly important priority across society, exhibitions focused on inclusive innovation play a vital role in connecting ideas with practical solutions. ABILITIES INDIA EXPO has established itself as one of India's leading events dedicated to accessibility by bringing together an exceptional range of exhibitors, industry experts, healthcare professionals, educators, government representatives, and community organizations.

Whether visitors are searching for advanced mobility equipment, rehabilitation technologies, adaptive educational resources, wellness products, or accessible living solutions, the expo provides an efficient platform for discovering trusted products and knowledgeable service providers. At the same time, businesses benefit from direct engagement with customers, partners, and industry stakeholders who are driving the future of accessibility.

More than a trade exhibition, ABILITIES INDIA EXPO represents a shared commitment to creating a more inclusive society where innovation supports independence, equal opportunities, and improved quality of life. By encouraging collaboration, promoting technological advancement, and expanding access to life-enhancing products and services, the event continues to strengthen India's accessibility ecosystem while helping shape a future in which everyone can participate more fully in education, employment, healthcare, and everyday life.

Annual Pharma IPR Conference: Intellectual Property and Innovation in the Pharmaceutical Industry

The Annual Pharma IPR Conference is an important professional gathering dedicated to intellectual property protection in the pharmaceutical and biopharmaceutical industries. As pharmaceutical companies invest in research, drug development, and advanced medical technologies, intellectual property rights play a central role in protecting innovation and supporting long-term business growth. The conference provides a platform for industry professionals to discuss patent strategies, regulatory challenges, licensing opportunities, and the relationship between innovation and access to medicines. By bringing attention to the legal, commercial, and ethical dimensions of pharmaceutical intellectual property, the event encourages knowledge exchange and helps participants better understand the issues shaping the future of healthcare innovation.

Understanding the Importance of Pharmaceutical Intellectual Property

The pharmaceutical industry operates in a complex environment where scientific discovery, regulatory compliance, commercial investment, and patient needs intersect. Developing a new medicine often requires years of research, extensive testing, specialized expertise, and substantial financial resources. Intellectual property protection helps companies safeguard the results of this work and establish a framework for commercializing new treatments.

The Annual Pharma IPR Conference focuses on the challenges associated with protecting intellectual property in this highly regulated sector. Patents, trademarks, trade secrets, and other forms of intellectual property can serve different purposes throughout the pharmaceutical value chain. Patents may protect qualifying inventions, trademarks help distinguish products in the marketplace, and trade secrets can safeguard confidential manufacturing methods or technical information.

For pharmaceutical and biopharmaceutical companies, understanding how these protections operate is essential to business planning. Effective intellectual property management can influence investment decisions, research partnerships, licensing agreements, and the introduction of new products into different markets. The conference provides an opportunity for professionals to examine these topics and discuss how intellectual property strategies can support responsible innovation.

Pharmaceutical Patents and the Development of New Medicines

Patents are particularly significant in pharmaceutical research because they can provide time-limited exclusive rights over qualifying inventions in the jurisdictions where protection is granted. These rights may help innovators attract investment and recover some of the costs associated with discovering, developing, testing, and bringing new medicines to market.

Drug development is rarely a straightforward process. Researchers investigate potential compounds, evaluate their properties, conduct preclinical studies, and undertake clinical trials to establish safety and effectiveness. Regulatory review and manufacturing preparation add further complexity before a medicine can become available to patients. Many research projects do not result in an approved product, making the financial risks of pharmaceutical innovation substantial.

Patent strategies therefore require careful planning. Companies must consider the nature of their inventions, the timing of applications, the relevant jurisdictions, and the relationship between patent protection and the wider product development process. Patent claims also need to be assessed against applicable legal requirements, including novelty, inventive step, and the rules governing patentable subject matter.

The Annual Pharma IPR Conference offers a setting for discussing these issues with professionals who understand the legal and commercial dimensions of pharmaceutical innovation. Such discussions can help companies identify challenges early, improve internal coordination, and develop more informed approaches to intellectual property management.

Balancing Intellectual Property Protection and Access to Medicines

One of the most important questions in pharmaceutical intellectual property is how to balance incentives for innovation with the need to make medicines available and affordable. Strong intellectual property rights can encourage investment in research, but questions may arise about medicine prices, competition, licensing, and access in lower-income or underserved markets.

This balance is particularly important when new treatments are introduced across different countries. Healthcare systems vary in their purchasing power, regulatory requirements, reimbursement arrangements, and distribution infrastructure. A medicine that is available in one market may take longer to reach patients elsewhere, even when there is a substantial medical need.

Intellectual property is only one factor affecting access to medicines. Manufacturing capacity, supply chains, healthcare funding, regulatory approval, procurement policies, and distribution systems can also influence availability. Understanding these interconnected factors is necessary for evaluating the broader effects of pharmaceutical patent policies.

The Annual Pharma IPR Conference creates an opportunity to discuss approaches that may support both innovation and access. These can include voluntary licensing, partnerships, technology transfer, differentiated commercial arrangements, and other mechanisms that may help medicines reach additional markets while respecting applicable legal rights.

No single approach is appropriate for every medicine or jurisdiction. The most effective strategies depend on the treatment involved, local healthcare needs, market conditions, and relevant legal frameworks. Open professional discussion can help stakeholders understand the available options and identify areas where cooperation may be beneficial.

The Role of Intellectual Property in Biopharmaceutical Innovation

Biopharmaceutical research has expanded the possibilities for treating a wide range of diseases through technologies involving biological materials, complex molecules, and advanced therapeutic approaches. This field requires specialized scientific expertise and often involves sophisticated research methods, manufacturing processes, and quality controls.

Intellectual property protection can support innovation in this environment by helping companies protect qualifying inventions and establish commercial arrangements around their development. However, the relevant intellectual property landscape may be complex. A single therapeutic product can involve several inventions, manufacturing techniques, delivery systems, and supporting technologies, each requiring careful legal and technical assessment.

Companies operating in biotechnology and biopharmaceuticals must also consider how research partnerships and collaborative development affect ownership and commercialization rights. Universities, research institutions, technology developers, and pharmaceutical companies may contribute different resources and expertise to a project. Clear agreements concerning intellectual property ownership, licensing, confidentiality, and future use can help reduce uncertainty.

The Annual Pharma IPR Conference provides a forum for examining these questions and discussing practical approaches to managing intellectual property across collaborative research and development activities. For organizations working with emerging therapies, these discussions can contribute to stronger planning and a clearer understanding of commercial opportunities and legal responsibilities.

The United States Pharmaceutical Industry and Global IP Development

The United States pharmaceutical and biopharmaceutical industries play a significant role in global research and development. Companies, universities, biotechnology firms, and research institutions contribute to the discovery of new medicines, the development of advanced technologies, and the creation of intellectual property associated with healthcare innovation.

The American research environment includes a range of public and private participants, from early-stage biotechnology companies to large pharmaceutical manufacturers. Investment, scientific infrastructure, specialist expertise, and collaboration between research organizations contribute to the development of new treatments and technologies. Intellectual property rights can form an important part of the process by helping organizations protect inventions and negotiate commercial agreements.

At the same time, the pharmaceutical sector operates within a wider international system. Patents are territorial rights, meaning that protection generally depends on the laws and procedures of individual jurisdictions. A company seeking to commercialize an invention in multiple countries must consider local patent requirements, regulatory approval processes, and market conditions.

International patent strategies therefore require coordination between scientific, legal, regulatory, and commercial teams. Companies must evaluate where protection is commercially justified and how intellectual property rights relate to their broader research and market-entry plans.

The Annual Pharma IPR Conference offers a setting for discussing these international considerations and exploring how companies can manage intellectual property across different regions. Such discussions are particularly valuable for organizations planning global development, licensing, or commercialization strategies.

Licensing, Collaboration, and Pharmaceutical Business Development

Licensing and collaborative agreements are important tools for translating pharmaceutical research into commercial products. A company may possess valuable intellectual property but lack the manufacturing capacity, distribution network, funding, or local market expertise needed to commercialize an invention independently. Partnerships can help bridge these gaps.

Licensing arrangements allow rights holders to authorize another organization to use specified intellectual property under agreed conditions. Depending on the agreement, a license may cover particular territories, fields of use, products, or periods. The commercial terms may include upfront payments, milestone payments, royalties, or other obligations.

Research collaborations can also help companies share expertise and resources. Pharmaceutical manufacturers may work with biotechnology firms, universities, research institutions, or specialist technology providers to advance promising projects. Clear agreements are important for defining ownership of existing intellectual property, rights to newly developed inventions, confidentiality obligations, and responsibilities for further development.

Professionals attending the Annual Pharma IPR Conference can use these topics as a starting point for examining partnership structures and commercial strategies. Discussions may help businesses identify potential areas of cooperation, understand common contractual considerations, and recognize the importance of aligning legal rights with practical development objectives.

Before entering into any licensing or collaboration agreement, organizations should conduct appropriate due diligence and obtain advice suited to the relevant jurisdictions. The value of a partnership depends not only on the underlying technology but also on the clarity of the agreement and the ability of the parties to fulfil their obligations.

Regulatory Compliance and Intellectual Property Risk Management

Pharmaceutical companies must manage intellectual property alongside a broad set of regulatory responsibilities. Medicines are subject to requirements relating to safety, efficacy, manufacturing quality, labelling, and marketing authorization. Intellectual property decisions can interact with these obligations, making coordination between legal, scientific, regulatory, and commercial teams particularly important.

A company developing a new medicine may need to evaluate patent protection, third-party rights, licensing obligations, and potential infringement risks as part of its development strategy. Freedom-to-operate assessments can help identify relevant intellectual property rights that may affect the planned manufacture or commercialization of a product. Such assessments are jurisdiction-specific and may need to be updated as projects evolve.

Organizations should also establish internal procedures for identifying and protecting valuable intellectual property. These may include invention disclosure processes, confidentiality policies, employee training, research documentation, and structured reviews of patent and licensing opportunities.

The Annual Pharma IPR Conference provides an opportunity to discuss these practical challenges and learn how different organizations approach intellectual property risk management. Sharing professional experience can help participants identify areas where internal procedures may need improvement and understand why early planning is important.

Effective risk management does not eliminate every legal or commercial uncertainty. Instead, it helps companies identify potential issues, evaluate available options, and make more informed decisions before significant resources are committed.

Key Topics for Professionals Attending the Annual Pharma IPR Conference

The pharmaceutical intellectual property landscape includes legal, technical, financial, and ethical considerations. Professionals from different backgrounds can benefit from examining these issues together, particularly when a decision in one area may affect research investment, product development, or access to medicines.

Important topics for discussion include:

Patent strategy: Understanding patentability, application timing, territorial protection, and the management of patent portfolios.
Drug development and innovation: Considering how intellectual property can support investment in pharmaceutical and biopharmaceutical research.
Access to medicines: Exploring the relationship between patent rights, licensing approaches, medicine availability, and healthcare needs.
International commercialization: Evaluating the challenges of protecting and commercializing inventions across multiple jurisdictions.
Licensing and partnerships: Understanding agreements that enable research collaboration, technology transfer, and product development.
Regulatory coordination: Considering how intellectual property planning interacts with pharmaceutical development and marketing requirements.
Risk management: Identifying potential intellectual property conflicts and establishing procedures to manage legal and commercial uncertainty.

These subjects are relevant to intellectual property lawyers, patent professionals, pharmaceutical executives, biotechnology companies, research organizations, licensing specialists, and business development teams. Bringing different perspectives together can help participants understand how intellectual property decisions affect the broader pharmaceutical ecosystem.

Preparing for a Productive Conference Experience

A well-planned conference visit can help participants focus on the topics most relevant to their responsibilities. Pharmaceutical intellectual property is a broad field, and professionals may attend for different reasons. Some may want to understand emerging patent challenges, while others may be interested in licensing opportunities, research partnerships, or international market strategies.

Before attending, participants should identify the questions they want to explore and review any relevant developments affecting their organizations. A pharmaceutical company preparing to enter a new market may need to examine territorial patent protection, while a biotechnology startup may be looking for ways to structure a licensing agreement. Legal professionals may focus on changes in patent practice, dispute risks, or the interaction between intellectual property and regulation.

The following steps can help make participation more effective:

Set clear objectives. Identify the legal, commercial, or research questions you want to address.
Review relevant information. Prepare a summary of your organization's current projects, intellectual property priorities, or partnership needs.
Identify useful contacts. Consider which types of professionals or organizations could provide relevant expertise.
Prepare specific questions. Focus on practical challenges rather than general topics alone.
Record important insights. Keep notes on discussions, potential partnerships, and issues requiring further investigation.
Plan follow-up actions. Share relevant findings with colleagues and arrange additional conversations where appropriate.

After the conference, participants can review their notes and determine which insights are most relevant to their organizations. Follow-up discussions, legal analysis, and internal planning may be necessary before applying new information to specific projects.

Supporting Innovation While Advancing Patient Care

Pharmaceutical innovation ultimately aims to improve the prevention, diagnosis, and treatment of disease. Intellectual property can contribute to this objective by supporting investment in research and providing a framework for the development and commercialization of new technologies. However, the broader value of innovation also depends on whether effective treatments can reach the people who need them.

This relationship makes pharmaceutical intellectual property an important topic for businesses, policymakers, researchers, legal professionals, and healthcare stakeholders. Patent protection, licensing decisions, regulatory requirements, manufacturing capacity, and healthcare purchasing arrangements can all influence how innovations move from research laboratories into clinical practice.

The Annual Pharma IPR Conference encourages discussion of these interconnected issues. By examining the commercial purpose of intellectual property alongside access and public health considerations, participants can develop a more comprehensive understanding of the challenges facing the pharmaceutical industry.

Responsible intellectual property management requires attention to both legal rights and the wider environment in which medicines are developed and supplied. Companies need strategies that protect legitimate innovation while recognizing the different conditions and healthcare requirements found across international markets.

Annual Pharma IPR Conference: A Platform for Pharmaceutical IP Excellence

The Annual Pharma IPR Conference provides a professional platform for exploring the role of intellectual property in pharmaceutical and biopharmaceutical innovation. Its central themes include patent protection, drug development, international commercialization, licensing, regulatory coordination, and the relationship between innovation incentives and access to medicines.

For pharmaceutical companies, the conference offers an opportunity to examine intellectual property strategies that support research investment and business development. Biotechnology firms and research institutions can explore questions surrounding collaborative innovation, licensing, and technology transfer. Legal professionals and patent specialists can discuss the challenges of managing intellectual property rights in a highly regulated and internationally connected industry.

The conference also highlights the importance of understanding the global pharmaceutical landscape, including the substantial contribution of the United States to research and development and the international nature of pharmaceutical commercialization. Because intellectual property rights operate within different national legal systems, effective strategies require careful planning and an understanding of local requirements.

By bringing these issues into a shared professional discussion, the Annual Pharma IPR Conference can help participants identify challenges, exchange expertise, and explore potential areas for cooperation.

Whether you work in pharmaceutical research, biotechnology, patent law, licensing, regulatory affairs, or business development, this event offers an opportunity to deepen your understanding of pharmaceutical intellectual property. Join the Annual Pharma IPR Conference to exchange knowledge, explore emerging challenges, build professional connections, and contribute to discussions about how intellectual property can support innovation and the future of patient care.

STI & HIV 2027 World Congress: Advancing Global Solutions for Sexual Health

The STI & HIV 2027 World Congress will bring together leading experts, researchers, healthcare professionals, policymakers, and community advocates from around the world to address some of the most pressing challenges in sexual health. Taking place at Bharat Mandapam, New Delhi, India, from 21–24 October 2027, the Congress is organized on behalf of the International Society for Sexually Transmitted Diseases Research (ISSTDR) and the International Union against Sexually Transmitted Infections (IUSTI). As one of the most significant international gatherings dedicated to sexually transmitted infections (STIs) and HIV, the event will serve as a global platform for scientific exchange, interdisciplinary collaboration, and evidence-based solutions.

Held under the theme "Evolving Challenges and Solutions," the Congress recognizes the rapidly changing landscape of sexually transmitted infections and HIV prevention, diagnosis, treatment, and public health. Advances in medical research, new technologies, changing epidemiological trends, and evolving healthcare systems require continuous collaboration among experts from multiple disciplines. The event aims to foster meaningful discussions that contribute to better prevention strategies, improved patient care, and stronger global health policies.

A Global Meeting for Researchers and Healthcare Professionals

The STI & HIV 2027 World Congress will welcome a diverse international community representing every aspect of sexual health research and clinical practice. Researchers, infectious disease specialists, clinicians, laboratorians, epidemiologists, public health officials, educators, policymakers, and community organizations will gather to exchange knowledge and share the latest scientific discoveries.

The multidisciplinary nature of the Congress creates an environment where experts from different fields can learn from one another and explore collaborative approaches to addressing global health challenges. By bringing together professionals with varied experiences and perspectives, the event encourages the development of innovative strategies that can be adapted to different healthcare systems and populations worldwide.

Participants will have the opportunity to engage directly with internationally recognized experts while exploring emerging research that has the potential to influence future clinical practice, public health initiatives, and policy development.

Exploring Emerging Challenges in Sexual Health

Sexually transmitted infections and HIV continue to present significant public health challenges despite major advances in prevention, diagnosis, and treatment. Changing patterns of disease transmission, antimicrobial resistance, healthcare inequalities, and evolving social determinants of health require continuous scientific investigation and international cooperation.

The Congress will focus on a broad range of important topics, including:

Advances in HIV prevention, diagnosis, and treatment.
Emerging research on sexually transmitted infections.
Public health strategies and disease surveillance.
Laboratory innovations and diagnostic technologies.
Antimicrobial resistance and clinical management.
Sexual health education and community engagement.
Health equity and access to care.
Digital health technologies and innovative healthcare solutions.

Through scientific presentations, panel discussions, workshops, and research sessions, participants will gain valuable insights into the latest developments shaping the future of sexual health worldwide.

Encouraging Collaboration and Knowledge Exchange

One of the defining strengths of the STI & HIV 2027 World Congress is its emphasis on international collaboration. Addressing complex global health challenges requires partnerships that extend across countries, healthcare systems, and scientific disciplines. The Congress provides an ideal setting for professionals to exchange ideas, discuss research findings, and develop collaborative initiatives that continue beyond the event itself.

Networking opportunities throughout the Congress will enable delegates to establish new professional relationships with colleagues, research institutions, public health agencies, and international organizations. These interactions often lead to joint research projects, multicenter clinical studies, educational initiatives, and policy collaborations that contribute to improved healthcare outcomes on a global scale.

Participants will also have the opportunity to learn from successful public health programs implemented in different regions, providing valuable insights that can be adapted to local healthcare environments and community needs.

Shaping the Future of Evidence-Based Sexual Health

Scientific evidence remains the foundation of effective public health policy and clinical care. The STI & HIV 2027 World Congress is committed to promoting evidence-based approaches that improve prevention, diagnosis, treatment, and long-term management of sexually transmitted infections and HIV. By showcasing the latest research and encouraging open scientific dialogue, the Congress supports the development of practical solutions that respond to evolving global health challenges.

The event also highlights the importance of innovation in modern healthcare. Advances in diagnostics, digital health technologies, epidemiological modeling, precision medicine, and implementation science continue to transform the way healthcare professionals address infectious diseases. The Congress will provide a platform for exploring these innovations while encouraging discussions about their practical application in diverse healthcare settings.

As global health priorities continue to evolve, international cooperation has never been more important. The STI & HIV 2027 World Congress will unite experts committed to improving sexual health through research, education, clinical excellence, and public health leadership. By fostering collaboration, encouraging scientific discovery, and supporting evidence-based practice, the Congress will contribute to stronger partnerships and more effective strategies for addressing sexually transmitted infections and HIV worldwide, helping improve health outcomes for communities across the globe.